Meningitis B Vaccination Programme Expanded to Year 11 Pupils in Kent
Health officials have announced an expansion of the meningitis B vaccination programme to include Year 11 pupils at schools affected by the ongoing outbreak in Kent. This decision comes as new figures from the UK Health Security Agency reveal a decline in confirmed cases of the illness.
Current Case Numbers and Vaccination Efforts
As of 12.30pm on Monday, 20 cases of meningitis had been confirmed, with a further three under investigation, bringing the total to 23. This represents a decrease from Sunday's figures, when 29 cases were reported, comprising 20 confirmed and nine under investigation.
The vaccination initiative began with University of Kent students on Wednesday, March 18. During a subsequent campus visit, Health Secretary Wes Streeting indicated the programme would be broadened to include sixth form pupils at four schools with known or suspected MenB cases. Ministers have now approved extending this offer to Year 11 pupils at these institutions as a precautionary measure to ensure longer-term protection.
By lunchtime on Monday, health officials had administered 13,088 doses of antibiotics alongside more than 10,000 vaccine doses throughout Kent.
UKHSA Analysis of Outbreak Drivers
The UKHSA has released detailed analysis examining three potential main drivers of the outbreak: the bacterial strain, immunity levels within the affected population, and social factors. The agency stated it is a realistic possibility that the strain is the primary driver, but emphasized that given the unusual nature of the outbreak, it is highly likely that all three factors are contributing.
Officials confirmed last week that the outbreak strain belongs to group B meningococci, featuring a recently emerged subtype present in England since 2020. The UKHSA suspects the bacteria's genome contains multiple potentially significant genetic differences compared to closely related genomes, which are currently being evaluated to understand how they might alter bacterial behavior.
Analysis indicates the strain responds to both antibiotics and the MenB vaccine. However, experts caution it is too early to determine if this strain causes more severe illness or exhibits higher transmissibility, with ongoing tests seeking clarity.
Demographic Details and Outbreak Timeline
The UKHSA confirmed cases have a median age of 19. While most affected individuals are students, five are not enrolled in education. A significant majority (87%) attended Club Chemistry in Canterbury at least once between March 5 and 7 before becoming unwell. Most attendees were students, and the three cases who did not visit the nightclub are all University of Kent students living in halls with connections to those who did attend.
The earliest known case became unwell on March 9, with the latest reported on March 16. The outbreak peaked on March 13, according to UKHSA data.
Patient Outcomes and Scientific Reassurance
All patients in the Kent outbreak have required hospital admission, with nine admitted to intensive care units where four remain. Tragically, two students have died: 18-year-old Juliette Kenny, described by her family as fit, healthy and strong before her death, and a University of Kent student.
Professor Robin May, chief scientific officer at UKHSA, commented: This preliminary analysis offers strong reassurance that our existing vaccinations and antibiotic treatment offer will be effective against this strain. In collaboration with the research community, we will continue intensive laboratory investigations of the strain to determine how the spread of the outbreak may have been influenced by the bacterial strain, social or environmental conditions, and population immunity.
